Moscow State Academy of Veterinary Medicine and Biotechnology – MVA named after K.I. Scrjabin (Professor)
Scientific and Practical Association of Veterinary Nephrologists and Urologists (President of Association)
Russian Federation
GRNTI 68.41 Ветеринария
Kidney diseases are quite common among cats, especially age-related ones. The article describes a study on comparative efficacy and safety of the drug Nephrospas, developed by «AVZ Ltd», Russia), which contains telmisartan and excipients and the drug Semintra®, developed by «Boehringer Ingelheim Vetmedica GmbH» (Germany), which also contains telmisartan as an active ingredient. Purpose of the study. To evaluate the clinical efficacy and safety of the drug Nefrospas in the treatment of cats with systemic hypertension and concomitant kidney disease (chronic kidney disease) stages 1-3 in comparison with the drug Semintra®. Materials and methods. The studies were carried out on 40 cats of different breeds aged 5 to 16 years, weighing 2.1…8.5 kg with arterial hypertension accompanied by chronic kidney disease, idiopathic hypertension, CKD and hyperparathyroidism. 2 groups of animals were formed: 1 experimental (Nefrospas) and 2 control or comparison (Semintra®), 10 animals in each group. Results and Conclusions. According to the results of comparative characteristic of the medicinal preparation Nefrospas with the analogue preparation, positive dynamics of reduction of total protein concentration, normalisation of pressure and increase of urine specific gravity were observed. This fact indicates restoration of functional activity of kidneys. The results of the clinical study of Nefrospas in cats with CKD of 1-3 degree according to IRIS classification demonstrated safety and efficacy of this drug for correction of hyposthenuria and nephrotoxic proteinuria. Summarising the results, we can conclude about the therapeutic equivalence and interchangeability of the domestic drug Nefrospas and foreign drug Semintra®. Nefrospas has shown similar results in the treatment of kidney diseases in cats, therefore its use is possible as a worthy alternative to the foreign drug.
medicinal product, telmisartan, Nephrospas, Semintra®, efficacy, kidney disease, cats
1. Rukovodstvo po eksperimental'nomu (doklinicheskomu) izucheniyu novyh farmakologicheskih veschestv // Pod obsch. Chlena-korrespondenta RAMN, professora red. R.U. Habrieva. - M.: Medicina, 2005. - 832 s.
2. Annikov, V.V. Ocenka terapevticheskoy effektivnosti gamavita v sostave kompleksnoy terapii pri lechenii koshek na vtoroy azotemicheskoy stadii hronicheskoy pochechnoy nedostatochnosti / V.V. Annikov, L.V. Annikova, M.A. Kol'dyaeva, E.S. Platicyna // Trudy Vserossiyskogo NII eksperimental'noy veterinarii im. Ya.R. Kovalenko. - 2018. - T. 80. - №. 2. - S. 14-17.
3. GOST 12.1.007-76 SSBT. Vrednye veschestva. Klassifikaciya i obschie trebovaniya bezopasnosti (s Izmeneniyami N 1, 2). Rezhim dostupa: https://docs.cntd.ru/document/5200233?ysclid=lmabciyrcx728881077
4. GOST 7.32-2001 SIBID. Otchet o nauchno-issledovatel'skoy rabote. Struktura i pravila oformleniya. Rezhim dostupa: https://docs.cntd.ru/document/1200026224?ysclid=lmabemnoe725007547
5. Postanovlenie Glavnogo gosudarstvennogo sanitarnogo vracha RF ot 29.08.2014 g. №51 «Ob utverzhdenii SP 2.2.1.3218-14 «Sanitarno-epidemiologicheskie trebovaniya k ustroystvu, oborudovaniyu i soderzhaniyu eksperimental'no-biologicheskih klinik (vivariev)». Rezhim dostupa: https://docs.cntd.ru/document/420219460?ysclid=lmabg466ll113045908
6. Pravila laboratornoy praktiki // Prikaz Ministerstva zdravoohraneniya Rossiyskoy Federacii № 708n ot 23.08.2010. Rezhim dostupa: https://normativ.kontur.ru/document?moduleId=1&documentId=165691&ysclid=lmabhw7r4q495378020
7. Rukovodstvo po provedeniyu doklinicheskih issledovaniy lekarstvennyh sredstv. Chast' pervaya // Pod red. A.N. Mironova. - M.: Grif i K, 2012. - 944 s.
8. Farafontova, V.S. Lechenie hronicheskoy pochechnoy nedostatochnosti u sobak i koshek/ V.S. Farafontova: avtoref. dis. …. kand. vet. nauk. - 2011. - 19 s.
9. FZ № 12 5 «Ob arhivnom dele v Rossiyskoy Federacii» ot 22.10.2004 s izmeneniyami na 13 maya 2008 g. Rezhim dostupa: https://docs.cntd.ru/document/901912288?ysclid=lmabl26f38626385098
10. Skosyrskih L.N. Primenenie telmisartana na doklinicheskoy stadii hronicheskoy bolezni pochek u koshek /L.N. Skosyrskih, A.S. // Voprosy normativno-pravovogo regulirovaniya v veterinarii - 2021. - №. 3. - S. 51-53.
